Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
Y. H. Choi, M. Hsu, C. Laaker, M. Herbath, H. Yang, P. Cismaru, A. M. Johnson, B. Spellman, K. Wigand, M. Sandor, Z. Fabry
This study shows that VEGF-C promotes brain infarcts after stroke, while blocking VEGFR-3 improves outcomes, highlighting a dual role for VEGF-C in stroke recovery.
bioRxiv · Aug 30, 2023Immunology
R. O'Keeffe, Y. Shirazi, S. Mehrdad, T. Crosby, A. M. Johnson, S. F. Atashzar
This paper evaluates functional perilaryngeal muscle networks in three voice disorder patients, finding altered connectivity and asymmetry compared to healthy controls, suggesting asymmetry as a biomarker for vocal hyperfunction.
bioRxiv · Jan 10, 2023 · PreprintBioengineering
E. K. Kleczko, T. K. Hinz, T. T. Nguyen, N. J. Gurule, A. Navarro, A. T. Le, A. M. Johnson, J. Kwak, D. I. Polhac, E. T. Clambey, M. C. Weiser-Evans, T. Patil, E. L. Schenk, L. E. Heasley, R. A. Nemenoff
This paper shows that adaptive immunity enhances the durability of alectinib response in EML4-ALK lung cancer models, with CD8+ T cells playing a key role.
bioRxiv · Apr 14, 2022 · PreprintCancer Biology
J. B. Glass, P. Ranjan, C. B. Kretz, B. L. Nunn, A. M. Johnson, M. Xu, J. McManus, F. J. Stewart
The paper investigates microbial metabolism and adaptations in Atribacteria-dominated methane hydrate sediments, identifying key metabolic pathways and stress responses.
bioRxiv · Jun 14, 2021Microbiology
A. M. Johnson, J. M. Boland, J. L. Wrobel, E. K. Klezcko, M. L. Weisner-Evans, L. Heasley, E. T. Clambey, R. L. Nemenoff, E. L. Schenk
The paper examines MHCII expression in NSCLC tumor microenvironment and finds it correlates with immune infiltration, spatial proximity, and improved survival.
bioRxiv · Feb 24, 2021Cancer Biology
A. M. Johnson, D. J. E. Huard, J. Kim, P. Raut, S. Dai, R. L. Lieberman, J. B. Glass
The paper identifies bacterial proteins that bind to gas clathrates and alter their morphology, suggesting potential industrial applications for clathrate control.
Crystal Growth & Design · Jul 23, 2020Peer-reviewedMicrobiology
M. M. Balas, E. W. Hartwick, C. Barrington, J. T. Roberts, S. K. Wu, R. Bettcher, A. M. Griffin, J. S. Kieft, A. M. Johnson
The paper shows that RNA matchmaking between HOTAIR and target gene RNAs relieves PRC2 inhibition, promoting its activity through structural changes and hnRNP B1-mediated interactions.
bioRxiv · Apr 13, 2020 · PreprintBiochemistry
J. L. Cornelison, M. L. Cato, A. M. Johnson, E. H. D'Agostino, D. Melchers, A. B. Patel, S. G. Mays, R. Houtman, E. A. Ortlund, N. T. Jui
This study develops a new class of LRH-1 agonists using a photoredox conjugate addition method, enabling bridgehead substitution to enhance ligand activation.
bioRxiv · Mar 16, 2020Biochemistry
A. M. Johnson, B. L. Bullock, A. J. Neuwelt, J. M. Poczobutt, R. E. Kaspar, H. Y. Li, J. W. Kwak, K. Hopp, M. C. M. Weiser-Evans, L. E. Heasley, E. L. Schenk, E. T. Clambey, R. A. Nemenoff
This study shows that cancer cell expression of MHCII affects T cell infiltration and response to anti-PD-1 therapy in lung adenocarcinoma.
bioRxiv · Jan 9, 2020 · PreprintCancer Biology
B. L. Bullock, A. K. Kimball, J. M. Poczobutt, H. Y. Li, J. W. Kwak, A. J. Neuwelt, A. M. Johnson, E. Kleczko, R. Kaspar, K. Hopp, E. Schenk, M. C. Weiser-Evans, E. T. Clambey, R. A. Nemenoff
This study identifies tumor-intrinsic IFN-gamma signaling as a determinant of anti-PD-1 response in NSCLC by altering the tumor microenvironment.
bioRxiv · Jan 27, 2019Cancer Biology